Ryman Healthcare Limited
RHCGF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $2 | $4 | $3 | $5 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $2 | $3 | $2 | $3 |
| Enterprise Value | $3 | $6 | $5 | $7 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 9.7% | 16.1% | 11.2% | – |
| Gross Profit | $1 | -$0 | -$0 | $0 |
| % Margin | 100% | -0.2% | -3.5% | 0.4% |
| EBITDA | -$0 | -$0 | $0 | $1 |
| % Margin | -3.8% | -7.8% | 81.8% | 156.5% |
| Net Income | -$0 | $0 | $0 | $1 |
| % Margin | -61.2% | 0.7% | 46% | 137.5% |
| EPS Diluted | -0.61 | 0.007 | 0.5 | 1.31 |
| % Growth | -8,940.6% | -98.6% | -61.8% | – |
| Operating Cash Flow | $0 | $1 | $1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |